February 2020

Reccan Diagnostics successfully raises SEK 15M in a new share issue. Read more here

May 2019

Sten K Johnson Foundation award "Development of a predictive and stratifying biomarker panel in pancreatic cancer tissue".

March 2019

Winner of the Lund University and Sparbanken Skåne award for future innovation "New serum test for diagnosis and prediction of pancreatic cancer".

March 2019

Sweden's Innovation Agency (Vinnova) - Grant for Innovative Startup.

March 2018

Lund University and Sparbanken Skåne honorary award for future innovation "Prognostic biomarker panel in pancreatic cancer".

June 2017

Sten K Johnson Foundation award "Histone 1.3 - a novel and unique biomarker for pancreatic cancer".

Read more

May 2016

Innovationskontor Syd - Accelarator grant. 

April 2016

Adjunct professor Lars Grundemar joins the board.

February 2016

Christer Fåhraeus joins the board after becoming co-owner.

December 2015

The research group behind Reccan Diagnostics receives SWELife/Vinnova funding of 1.5 MSEK "Development of a novel diagnostic and prognostic biomarker panel in blood in pancreatic cancer".

Read more

July 2015

LU Holding becomes co-owner and Christine Widstrand joins the board.

October 2014

The company was founded.